1. Home
  2. PAX vs DMRA Comparison

PAX vs DMRA Comparison

Compare PAX & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patria Investments Limited

PAX

Patria Investments Limited

N/A

Current Price

$11.25

Market Cap

1.8B

Sector

Finance

ML Signal

N/A

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$28.14

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAX
DMRA
Founded
1988
2011
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
PAX
DMRA
Price
$11.25
$28.14
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$18.00
$43.00
AVG Volume (30 Days)
1.2M
316.3K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
4.81%
N/A
EPS Growth
N/A
121.48
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.99
N/A
Revenue Next Year
$16.52
N/A
P/E Ratio
$25.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.55
$16.50
52 Week High
$17.80
$34.89

Technical Indicators

Market Signals
Indicator
PAX
DMRA
Relative Strength Index (RSI) 47.81 41.90
Support Level $11.04 $28.16
Resistance Level $11.58 $28.66
Average True Range (ATR) 0.32 1.58
MACD -0.02 -0.42
Stochastic Oscillator 39.39 25.37

Price Performance

Historical Comparison
PAX
DMRA

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: